Dickkopf-1 is involved in BMP9-induced osteoblast differentiation of C3H10T1/2 mesenchymal stem cells
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Bone morphogenetic protein 9 (BMP9) is a potent inducer of osteogenic differentiation of mesenchymal stem cells. The Wnt antagonist Dickkopf-1 (Dkk1) is involved in skeletal development and bone remodeling. Here, we investigated the role of Dkk1 in BMP9-induced osteogenic differentiation of MSCs. We found that overexpression of BMP9 induced Dkk1 expression in a dose-dependent manner, which was reduced by the P38 inhibitor SB203580 but not the ERK inhibitor PD98059. Moreover, Dkk1 dramatically decreased not only BMP9-induced alkaline phosphatase (ALP) activity but also the expression of osteocalcin (OCN) and osteopontin (OPN) and matrix mineralization of C3H10T1/2 cells. Furthermore, exogenous Dkk1 expression inhibited Wnt/β-catenin signaling induced by BMP9. Our findings indicate that Dkk1 negatively regulates BMP9-induced osteogenic differentiation through inhibition of the Wnt/β-catenin pathway and it could be used to optimize the therapeutic use of BMP9 and for bone tissue engineering.
Abstract
Bone morphogenetic protein 9 (BMP9) is a potent inducer of osteogenic differentiation of mesenchymal stem cells. The Wnt antagonist Dickkopf-1 (Dkk1) is involved in skeletal development and bone remodeling. Here, we investigated the role of Dkk1 in BMP9-induced osteogenic differentiation of MSCs. We found that overexpression of BMP9 induced Dkk1 expression in a dose-dependent manner, which was reduced by the P38 inhibitor SB203580 but not the ERK inhibitor PD98059. Moreover, Dkk1 dramatically decreased not only BMP9-induced alkaline phosphatase (ALP) activity but also the expression of osteocalcin (OCN) and osteopontin (OPN) and matrix mineralization of C3H10T1/2 cells. Furthermore, exogenous Dkk1 expression inhibited Wnt/β-catenin signaling induced by BMP9. Our findings indicate that Dkk1 negatively regulates BMP9-induced osteogenic differentiation through inhibition of the Wnt/β-catenin pathway and it could be used to optimize the therapeutic use of BMP9 and for bone tissue engineering.
참고문헌 (37)
- Cheng H, "Osteogenic activity of the fourteen types of human bone morphogenetic proteins(BMPs)", J Bone Joint Surg Am, 85-a, pp.1544~1552 (2003)
- Miyazono K, "Bone morphogenetic protein receptors, signal transduction", J Biochem, 147, pp.35~51 (2010)
- Lamplot JD, "BMP9 signaling in stem cell differentiation, osteogenesis", Am J Stem Cells, 2, pp.1~21 (2013)
- Song JJ, "Bone morphogenetic protein-9 binds to liver cells, stimulates proliferation", Endocrinology, 136, pp.4293~4297 (1995)
- Luu HH, "Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells", J Orthop Res, 25, pp.665~677 (2007)
- Luther G, "BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism, therapeutic potential", Curr Gene Ther, 11, pp.229~240 (2011)
- Zhang Y, "A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2", Proc Natl Acad Sci U S A, 108, pp.9863~9868 (2011)
- Zhao GQ, "Consequences of knocking out BMP signaling in the mouse", Genesis, 35, pp.43~56 (2003)
- Wang J, "The canonical Wnt pathway in early mammalian embryogenesis, stem cell maintenance", differentiation, 2004, pp.14, 533~539
- Clevers H, "Wnt", beta-catenin signaling in development, disease, 2006, pp.127, 469~480
- Glass DA 2nd, "In vivo analysis of Wnt signaling in bone", Endocrinology, 148, pp.2630~2634 (2007)
- Boyden LM, "High bone density due to a mutation in LDL-receptor-related protein 5", N Engl J Med, 346, pp.1513~1521 (2002)
- Day TF, "Wnt", beta-catenin signaling in mesenchymal progenitors controls osteoblast, chondrocyte differentiation during vertebrate skeletogenesis, 2005, pp.8, 739~750
- Kawano Y, "Secreted antagonists of the Wnt signalling pathway", J Cell Sci, 116, pp.2627~2634 (2003)
- Mukhopadhyay M, "Dickkopf1 is required for embryonic head induction, limb morphogenesis in the mouse", Dev Cell, 1, pp.423~434 (2001)
- Li J, "Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia", Bone, 39, pp.754~766 (2006)
- Morvan F, "Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation, bone mass", J Bone Miner Res, 21, pp.934~945 (2006)
- Hall CL, "Prostate cancer cells promote osteoblastic bone metastases through Wnts", Cancer Res, 65, pp.7554~7560 (2005)
- Tian E, "The role of the Wnt-signaling antagonist Dkk1 in the development of osteolytic lesions in multiple myeloma", N Engl J Med, 349, pp.2483~2494 (2003)
- Tang N, "BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt", beta-catenin signalling, 2009, pp.13, 2448~2464
- Kim HK, "High-concentration of BMP2 reduces cell proliferation, increases apoptosis via Dkk1, SOST in human primary periosteal cells", Bone, 54, pp.141~150 (2013)
- Zhang H, "Canonical Wnt signaling acts synergistically on BMP9-induced osteo", odontoblastic differentiation of stem cells of dental apical papilla(SCAPs), 2015, pp.39, 145~154
- Lou J, "Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1", 2, 2000, pp.268, 757~762
- Dao-jing Xu, "Smads, p38 and ERK1", 2 are involved in BMP9-induced osteogenic differentiation of C3H10T1, BMB Reports, pp.2012, 45(4)[DOI]
- Liao J, "Sox9 potentiates BMP2-induced chondrogenic differentiation, inhibits BMP2-induced osteogenic differentiation", PLoS One, 9, pp.e89025~ (2014)
- Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
- Petite H, "Tissue-engineered bone regeneration", Nat Biotechnol, 18, pp.959~963 (2000)
- Kang Q, "Characterization of the distinct orthotopic bone-forming activity of 14BMPs using recombinant adenovirus-mediated gene delivery", Gene Ther, 11, pp.1312~1320 (2004)
- Diarra D, "Dickkopf-1 is a master regulator of joint remodeling", Nat Med, 13, pp.156~163 (2007)
- Weng LH, "Inflammation induction of Dickkopf-1 mediates chondrocyte apoptosis in osteoarthritic joint", Osteoarthritis Cartilage, 17, pp.933~943 (2009)
- Kamiya N, "Wnt inhibitors Dkk1, Sost are downstream targets of BMP signaling through the type IA receptor(BMPRIA)in osteoblasts", J Bone Miner Res, 25, pp.200~210 (2010)
- Nakashima K, "The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation, bone formation", Cell, 108, pp.17~29 (2002)
- Zhang C, "Characterization of Dkk1 gene regulation by the osteoblast-specific transcription factor Osx", Biochem Biophys Res Commun, 420, pp.782~786 (2012)
- Zuzarte-Luis V, "A new role for BMP5 during limb development acting through the synergic activation of Smad, MAPK pathways", Dev Biol, 272, pp.39~52 (2004)
- Zhang R, "Wnt", beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts, 2013, pp.52, 145~156
- Butler JS, "Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation", BMC Musculoskelet Disord, 11, pp.210~ (2010)
- Luo J, "A protocol for rapid generation of recombinant adenoviruses using the AdEasy system", Nat Protoc, 2, pp.1236~1247 (2007)
